- Home
- KLRS vs SHIP Comparison
KLRS vs SHIP Comparison
Compare KLRS & SHIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- SHIP
- Stock Information
- Founded
- KLRS 2019
- SHIP 2008
- Country
- KLRS United States
- SHIP Greece
- Employees
- KLRS N/A
- SHIP N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- SHIP Marine Transportation
- Sector
- KLRS Health Care
- SHIP Consumer Discretionary
- Exchange
- KLRS Nasdaq
- SHIP Nasdaq
- Market Cap
- KLRS 129.0M
- SHIP 114.3M
- IPO Year
- KLRS N/A
- SHIP 2007
- Fundamental
- Price
- KLRS $3.89
- SHIP $5.60
- Analyst Decision
- KLRS Buy
- SHIP Strong Buy
- Analyst Count
- KLRS 1
- SHIP 1
- Target Price
- KLRS N/A
- SHIP $11.00
- AVG Volume (30 Days)
- KLRS 62.9K
- SHIP 81.2K
- Earning Date
- KLRS 05-19-2025
- SHIP 05-19-2025
- Dividend Yield
- KLRS N/A
- SHIP 14.02%
- EPS Growth
- KLRS N/A
- SHIP 1658.44
- EPS
- KLRS N/A
- SHIP 2.11
- Revenue
- KLRS N/A
- SHIP $167,459,000.00
- Revenue This Year
- KLRS N/A
- SHIP N/A
- Revenue Next Year
- KLRS N/A
- SHIP $21.30
- P/E Ratio
- KLRS N/A
- SHIP $2.57
- Revenue Growth
- KLRS N/A
- SHIP 51.91
- 52 Week Low
- KLRS $4.19
- SHIP $4.78
- 52 Week High
- KLRS $24.15
- SHIP $13.19
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- SHIP 47.46
- Support Level
- KLRS N/A
- SHIP $5.37
- Resistance Level
- KLRS N/A
- SHIP $5.85
- Average True Range (ATR)
- KLRS 0.00
- SHIP 0.20
- MACD
- KLRS 0.00
- SHIP 0.05
- Stochastic Oscillator
- KLRS 0.00
- SHIP 69.74
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Fellowship, Championship, Partnership, Knightship, Lordship, Gloriuship, Leadership, Geniuship, Premiership, and Squireship, among others.